The Marfan syndrome has been linked to the FBN1 gene encoding the micr
ofibrillar glycoprotein fibrillin. To date, there have been no descrip
tions of microfibrillar abnormalities characteristic of this connectiv
e tissue disorder, although biochemical analyses have highlighted appa
rent abnormalities in fibrillin synthesis, secretion and processing. W
e have conducted a biochemical and ultrastructural investigation of fi
brillin expression and assembly by a panel of dermal fibroblast lines
from patients with Marfan syndrome and related diseases. The study has
highlighted marked differences between cells in terms of secretion an
d aggregation of newly-synthesised fibrillin. In addition, electron mi
croscopic visualization of fibrillin assemblies has clearly demonstrat
ed for the first time the plethora of microfibrillar abnormalities tha
t underlie this heterogeneous disorder. These data emphasize the molec
ular complexity that is a feature of the diverse clinical phenotypes e
xhibited by Marfan patients.